Back to all Programs

Past Event

Related Materials

Past Event

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Viral Hepatitis and Liver Disease

Current and Future Treatment of CMV | Robin Avery, MD

Viral Hepatitis and Liver Disease

Current Challenges in Pediatric Drug Development | Robert Ward, MD, FAAP, FCP

Viral Hepatitis and Liver Disease

Clinical Aspects of Pediatric Treatment | Tim Cressey, PhD

Viral Hepatitis and Liver Disease

HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH

Viral Hepatitis and Liver Disease

FDA perspective | Kellie Reynolds, PharmD

Viral Hepatitis and Liver Disease

DDI’s in Aging HCV infected Patients | Elise Smolders, MSc

Viral Hepatitis and Liver Disease

Long Acting Antivirals: Advanced drug delivery | Mark Milad, PharmD

Viral Hepatitis and Liver Disease

Pro Standpoint | Nancy Reau, MD

Viral Hepatitis and Liver Disease

Con Standpoint | Jürgen Rockstroh, MD

Viral Hepatitis and Liver Disease

Merck: CMV | Cyrus Badshah, MD, PhD

Viral Hepatitis and Liver Disease

Janssen: Influenza | Thomas Kakuda, PharmD

Viral Hepatitis and Liver Disease

Gilead: RSV | Erik Mogalian